Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.09
+0.47 (6.17%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $528.48 million as of July 30, 2026. Its market cap has decreased by -30.12% in one year.
Market Cap
528.48M
Enterprise Value
565.72M
1-Year Change
-30.12%
Ranking
Category
Stock Price
$8.09
ChartMarket Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $528.48M, a decrease of -75.78%. That is a compound annual growth rate of -23.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 528.48M | 11.89% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 520.21M |
| Shattuck Labs | 516.44M |
| Zura Bio | 511.09M |
| Eikon Therapeutics | 506.47M |
| Artiva Biotherapeutics | 499.73M |
| 4D Molecular Therapeutics | 498.19M |
| Rezolute | 494.13M |
| Adlai Nortye | 493.40M |